Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

ENDRA Life Sciences (NDRA) Shares Outstanding (2016 - 2025)

ENDRA Life Sciences has reported Shares Outstanding over the past 6 years, most recently at $2.1 million for Q4 2021.

  • Quarterly Shares Outstanding rose 24.98% to $2.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2021, up 24.98% year-over-year, with the annual reading at $2.1 million for FY2021, 24.98% up from the prior year.
  • Shares Outstanding was $2.1 million for Q4 2021 at ENDRA Life Sciences, down from $42.2 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $42.2 million in Q3 2021 and troughed at $196.0 in Q4 2020.
  • The 5-year median for Shares Outstanding is $3.9 million (2017), against an average of $9.8 million.
  • The largest YoY upside for Shares Outstanding was 34128.77% in 2021 against a maximum downside of 99.14% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $3.9 million in 2017, then surged by 89.98% to $7.4 million in 2018, then increased by 13.46% to $8.4 million in 2019, then crashed by 79.78% to $1.7 million in 2020, then rose by 24.98% to $2.1 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Shares Outstanding are $2.1 million (Q4 2021), $42.2 million (Q3 2021), and $141397.0 (Q2 2021).